tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
with an average price target of $10.05. This is a potential upside of $10.05 (0%) from yesterday's end of day stock price of $0.
Concert Pharmaceuticals's activity chart (see below) currently has 62 price targets and 52 ratings on display.
Analysts average stock forecasts to be materialized ratio is 21.7% with an average time for these price targets to be met of 219.9 days.
Most recent stock forecast was given by STEPHEN KIM from EVERCORE on 20-Jan-2023. First documented stock forecast 08-Jul-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$17
3 years 2 months 16 days ago
(20-Jan-2023)
0/1 (0%)
$10.12 (147.09%)
Buy
$25
3 years 2 months 17 days ago
(19-Jan-2023)
0/6 (0%)
$18.01 (257.65%)
Buy Since 04-Sep-2019
$11
$2.63 (31.42%)
$25
3 years 10 months 13 days ago
(23-May-2022)
0/5 (0%)
$6.9 (168.29%)
Buy Since 24-Jul-2017
$17
$8.63 (103.11%)
$17
3 years 10 months 13 days ago
(23-May-2022)
1/7 (14.29%)
$12.9 (314.63%)
115
Buy Since 04-Nov-2020
$10
$1.63 (19.47%)
4 years 4 months 24 days ago
(12-Nov-2021)
0/2 (0%)
$6 (150.00%)
What is CNCE (Concert Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CNCE (Concert Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CNCE (Concert Pharmaceuticals)?
Which analyst is the currently most bullish on CNCE (Concert Pharmaceuticals)?
Which analyst is the currently most reserved on CNCE (Concert Pharmaceuticals)?
